Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers
Women with Ovarian Cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.
You may be eligible to participate in this study if you:
- Are a female at least 18 years of age
- Have a confirmed diagnosis of high-grade serous EOC, primary peritoneal cancer, or fallopian tube cancer
- Have platinum-resistant disease
- Have completed any major surgery at least 4 weeks prior to first dose of
MIRV and have recovered or stabilized from the side effects of prior surgery
- Have adequate hematologic, liver and kidney functions
You may NOT participate in this study if you:
- Have primary platinum-refractory disease
- Have folate deficiency (take folate supplements)
- Have active or chronic corneal disorders, history of corneal transplantation, or active ocular conditions requiring ongoing treatment/monitoring
- Have a serious concurrent illness or clinically relevant active infection
- Have a clinically significant cardiac disease
- Have a history of hemorrhagic or ischemic stroke or a history of cirrhotic liver disease
- Are pregnant or breastfeeding
Contact Information
Martina Kracikova, Study Coordinator
One Gustave L. Levy Place, Box 1170 New York, NY 10029
Phone: (212)-824-7859
Fax: (212) 824 2347
Email: martina.kracikova@mssm.edu